SCHEMBL28296060

SCHEMBL28296060

Cc1cccc(N(C)O[SH](=O)=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 6/20 0.41
▸ HSD17B2 P37059 6/20 0.41
▸ ACHE P22303 2/20 0.39
▸ SIGMAR1 Q99720 1/20 0.38
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ CYP51A1 Q16850 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28847949 0.80 — —
Water SCHEMBL27669581 0.79 — —
SCHEMBL27294646 0.78 HTT (0.43) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL22415256 0.76 ACHE (0.46) HSD17B1HSD17B2ACHESIGMAR1CYP3A4
SCHEMBL28168182 0.76 ALDH1A1 (0.46) ACHECYP3A4CYP2C19TDP1LMNA
SCHEMBL28838693 0.76 HSD17B10 (0.43) CYP2C9TDP1LMNACYP1A2MAPT
SCHEMBL18808725 0.75 ACHE (0.44) HSD17B1HSD17B2ACHESIGMAR1CYP3A4
SCHEMBL28143850 0.74 LOXL2 (0.45) MAPTALDH1A1NPC1RAB9APOLB
SCHEMBL27362374 0.73 KMT2A (0.40) HSD17B2TDP1LMNAMAPTALDH1A1
SCHEMBL1697445 0.71 ACHE (0.55) HSD17B1HSD17B2ACHESIGMAR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107056799-B The double heptene sulfamide compounds of suberic acid monoanilide group oxygen bridge, its synthetic method, application and anti-breast cancer medicines composition 武汉宏兹生物技术有限公司 2019-06-14 — — CN disclosed
CN-107056799-A The double heptene sulfamide compounds of suberic acid monoanilide group oxygen bridge, its synthetic method, using and anti-breast cancer medicines composition 武汉宏兹生物技术有限公司 2017-08-18 — — CN disclosed
Send feedback